A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Participants will receive a dose of Gamma-PN and serum will be collected pre dose and Day 28
Inclusion Criteria:
Exclusion Criteria:
nerissa@gpnvaccines.com+61-432 161 783
paul@gpnvaccines.com+61-405 670 420